Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial - Concepedia

Concepedia

Publication | Closed Access

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

516

Citations

25

References

2019

Year

Kathleen N. Moore, Angeles Alvarez Secord, Melissa A. Geller, David S. Miller, Noelle Cloven, Gini F. Fleming, Andrea E. Wahner Hendrickson, Masoud Azodi, Paul DiSilvestro, Amit M. Oza,

The Lancet Oncology

OncologyMetronomic TherapyGynecologyNiraparib MonotherapyLate-line TreatmentCancer TreatmentMedicineGynecology OncologyOvarian Cancer

References

	Year	Citations

Page 1

Page 1